LEADER 00728nam2 22002171i 450 
001 990002303740403321
035   $a000230374
035   $aFED01000230374
035   $a(Aleph)000230374FED01
035   $a000230374
100   $a20030801d--------km-y0itay50------ba
200 1 $aDrug utilization strategies within regional programs on drug control and evaluation.Oxford, 1979, v. 6, p. 101-112.
463  0$1001000221847
701  1$aTognoni,$bG.$099521
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002303740403321
959   $aFFABC
996   $aDrug utilization strategies within regional programs on drug control and evaluation.Oxford, 1979, v. 6, p. 101-112$9388142
997   $aUNINA
DB    $aING01

LEADER 01138nam--2200397---450-
001 990000668250203316
005 20090205182749.0
010   $a88-7187-118-9
035   $a0066825
035   $aUSA010066825
035   $a(ALEPH)000066825USA01
035   $a0066825
100   $a20011005d1992----km-y0itay0103----ba
101   $aita
102   $aIT
105   $a||||||||001yy
200 1 $a<<Le>> borse estere$fAdamo Gentile$gprefazione a cura di Oppenhemer & Co.
210   $aMilano$cIl Sole 24 ore libri$d1992
215   $a213 p.$d21 cm
225 2 $aL'esperto risponde
410   $12001$aL'esperto risponde
461  1$1001-------$12001
606 0 $aBorse
676   $a332.642
700  1$aGENTILE,$bAdamo$0116061
801  0$aIT$bsalbc$gISBD
912   $a990000668250203316
951   $a332.642 GEN 1 (IRA 30 41)$b330 EC$cIRA 30$d00012342
959   $aBK
969   $aECO
979   $aPATTY$b90$c20011005$lUSA01$h1318
979   $c20020403$lUSA01$h1716
979   $aPATRY$b90$c20040406$lUSA01$h1646
979   $aRSIAV3$b90$c20090205$lUSA01$h1827
996   $aBorse estere$9195118
997   $aUNISA